In this free webinar, delve into the evolving role of machine learning (ML) and artificial intelligence (AI) in drug discovery. Attendees will learn how the Cambridge Structural Database (CSD) can train and advance AI/ML models. The featured speakers will highlight the value of high-quality, curated data and why the CSD is a trusted resource for quality data management.
TORONTO, June 5, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar on the transformative impact of machine learning (ML) and artificial intelligence (AI) in life sciences. Attendees will gain insights into the challenges, including data quality and ethics, and how the findable, accessible, interoperable and reusable (FAIR) data principles and the Cambridge Structural Database (CSD) can advance AI applications.
Although significant barriers still exist, the outcomes of using ML and AI in life science industries, as well as healthcare, green energy and technology, could be revolutionary. Challenges span political will, sustainability, ethics, infrastructure and the talent pipeline. A basic limitation for many, however, is simply the availability, quality and trustworthiness of data, including data for testing, training and validating models.
The FAIR guiding principles for scientific data management and stewardship[1] were published in 2016 to formalize the priorities for enhancing data's machine-actionability.
Data that are AI-ready need to be properly standardized, curated, interoperable, be of high quality and appropriately defined with standardized metadata. This ensures that the data are usable now and in the future for humans and machines.
The CSD has already been used to train ML models relevant to the pharmaceutical industry, e.g., to help predict aqueous solubility,[2] and its application for training ML models for drug discovery is already recognized[3].
The CSD contains over 1.28 million fully curated small-molecule organic and metal–organic crystal structures and is fundamentally structured and designed to be underpinned by FAIR data principles. This, along with being a CoreTrustSeal-certified data repository, mark the CSD as a trusted and high-quality resource that could break down some of the barriers preventing the advancement of ML and AI in life sciences.
Register for this webinar to learn about the challenges of using ML and AI in life sciences, the importance of quality data management and why the CSD is trusted by academic and industrial institutions around the world.
Join Dr. Ola Engkvist, Head of Molecular AI in Discovery Sciences, AstraZeneca, Dr. Jonathan Betts, Senior Leadership Team, CCDC; and Dr. Clare Tovee, Senior Scientific Editor, CCDC, for the live webinar on Wednesday, June 19, 2024, at 10am EDT (3pm BST/UK).
For more information, or to register for this event, visit ML and AI in Life Sciences: Breaking Down Barriers.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
References:
[1] Wilkinson, M.D., Dumontier, M., Aalbersberg, I.J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.W., da Silva Santos, L.B., Bourne, P.E. and Bouwman, J., 2016. The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data, 3(1), pp.1-9.
[2] Zhu, X., Polyakov, V.R., Bajjuri, K., Hu, H., Maderna, A., Tovee, C.A. and Ward, S.C., 2023. Building machine learning small molecule melting points and solubility models using CCDC melting points dataset. Journal of Chemical Information and Modeling, 63(10), pp.2948-2959.
[3] Kalash, L.N., Cole, J.C., Copley, R.C., Edge, C.M., Moldovan, A.A., Sadiq, G. and Doherty, C.L., 2021. First global analysis of the GSK database of small molecule crystal structures. CrystEngComm, 23(32), pp.5430-5442.
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article